Day: August 7, 2020

BOSTON, Aug. 07, 2020 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on Friday, August 14, 2020, at 8:30 a.m. ET to discuss its second quarter 2020 financial results and other business updates.A live webcast will be available under “Events and Presentations” in the Investors section of the company’s website at imaratx.com. The conference call can be accessed by dialing 1 (833) 519-1307 (U.S. domestic) or +1 (914) 800-3873 (international) and referring to conference ID 9775635. A replay of the webcast will be archived on the Imara website following the...

TORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Rogers Communications today launched a fundraising campaign to support the Orange Shirt Society, which aims to educate Canadians on the history and impact of our country’s residential school system and advocate for action on reconciliation. Starting today, ahead of World Indigenous Peoples’ Day this Sunday, a special orange t-shirt designed by Ojibwe artist Patrick Hunter will be showcased across Rogers-owned media assets including TSC (Today’s Shopping Choice) and available at tsc.ca/wewearorange, with proceeds from sales going to the organization’s ongoing efforts to expand Indigenous education across Canada.Commissioned by Rogers, the orange t-shirt designed by Hunter was unveiled in June in honour of National Indigenous Peoples’ Day. Now, as we step towards Orange Shirt Day on September...

Soulignez la Journée internationale des peuples autochtones dimanche en achetant un t-shirt conçu sur commande pour Rogers Le produit des ventes sera remis à l’Orange Shirt Society afin d’aider à faire connaître l’histoire des Autochtones partout au CanadaTORONTO, 07 août 2020 (GLOBE NEWSWIRE) — Rogers Communications a lancé aujourd’hui une campagne de financement pour soutenir l’Orange Shirt Society, dont la mission est de faire connaître aux Canadiennes et Canadiens l’histoire ainsi que les répercussions du système des pensionnats de notre pays et de militer en faveur de mesures de réconciliation. À compter d’aujourd’hui, avant la Journée internationale des peuples autochtones, ce dimanche, un t-shirt orange spécial conçu par Patrick Hunter, artiste ojibwé, sera présenté dans tous les actifs médiatiques appartenant à Rogers, y...

WYOMISSING, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (the “Company”), announced today that at its meeting yesterday, the Company’s Board of Directors declared the third quarter 2020 dividend of $0.60 per share of its common stock, consisting of a combination of cash and shares of the Company’s common stock. The dividend is payable on September 25, 2020 to shareholders of record on August 17, 2020. The cash component of the dividend (other than cash paid in lieu of fractional shares) will not exceed 20% in the aggregate, or $0.12 per share, with the balance, or $0.48 per share, payable in shares of the Company’s common stock. As previously announced, the quarterly dividend level reflects the impact of the COVID-19 closures on the Company’s business and anticipates...

TORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the three months ended June 30, 2020.As previously disclosed, all financial figures are now reported in US dollars unless indicated otherwise.Financial Overview (3 months results)Assets Under Management (“AUM”) were $13.9 billion as at June 30, 2020, up $3.2 billion (29%) from March 31, 2020.Total net revenues (net of commission expenses, trailer fees and sub-advisor fees, carried interest and performance fee payouts) were $28.3 million, reflecting an increase of $13.4 million (90%) from the 3 months ended June 30, 2019.Total expenses (excluding commission expenses, trailer fees and sub-advisor fees, carried interest and performance fee payouts) were $16.2 million, reflecting an increase of...

DEERFIELD, Ill., Aug. 07, 2020 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today reported operating results for the second quarter of 2020. The sale of RTI Surgical Holdings, Inc.’s (“RTI”) OEM business closed on July 20, 2020, accordingly, the reported consolidated financial results for the second quarter include results for the OEM and Spine segments.Second Quarter 2020 Highlights:Consolidated revenue of $54.2 million, compared to $81.6 million in the second quarter of 2019Spine revenue of $20.5 million, compared to $32.6 million in the second quarter of 2019Net loss of $38.7 million inclusive of approximately $15.5 million of non-recurring expensesAdjusted EBITDA loss of $5.3 millionRecent Highlights:Following...

NEW HAVEN, Conn., Aug. 07, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Friday, August 14, 2020 at 8:30 AM Eastern Time to discuss its second quarter 2020 operating and financial results.Conference Call & Webcast DetailsDate/Time: Friday, August 14, 2020, 8:30 AM Eastern TimeDomestic: 877-407-2985International: 201-378-4915The webcast will be accessible* under “Events” on the News & Media page of the Company’s website at www.bioxceltherapeutics.com.ReplayDomestic: 877-660-6853International: 201-612-7415Conference ID: 13708104*Replay available through at least...

WAYNE, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the second quarter of 2020 and provided research and development (R&D) and business highlights.“As the pandemic evolves, our team has continued to work hard to make the appropriate business adjustments, advance our pipeline and execute through these uncertain times,” said Dr. Neal Walker, President and CEO of Aclaris. “In the second quarter, we dosed the first subject in our Phase 2a trial of ATI-450 as a potential treatment for moderate to severe rheumatoid arthritis. We are also proud to be participating in the effort to find effective therapeutics for COVID-19 by supporting...

GAITHERSBURG, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has completed enrollment in its Phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate. With this milestone, the data readout for the Day 28 immunogenicity endpoint remains on target for Q4 2020.The clinical trial has enrolled 42 evaluable healthy subjects to receive intranasally administered NasoShield or placebo and be followed for 6 months following dosing. The primary immunogenicity readouts are the serum antibody response to protective antigen and toxin-neutralizing antibody titer 28 and 56 days after dosing. As with Altimmune’s other vaccine programs, stimulation of a mucosal IgA immune response in the nasal cavity will also be assessed as...

Seoul, Aug. 07, 2020 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its unaudited financial results for the second quarter ended June 30, 2020, prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and business updates.SECOND QUARTER 2020 HIGHLIGHTSTotal revenues were KRW 88,458 million (US$ 73,684 thousand), representing a 20.7% increase from the first quarter ended March 31, 2020 (“QoQ”) and a 13.2% increase from the second quarter ended June 30, 2019 (“YoY”).Operating profit was KRW 16,313 million (US$ 13,588 thousand), representing a 57.5% increase QoQ and a 25.5% increase YoY.Profit before income tax expenses was KRW 16,335million...